ZNF550
gene geneOn this page
Also known as MGC41917
Summary
ZNF550 (zinc finger protein 550, HGNC:28643) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 550 (Q7Z398). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 162972 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001397372
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28643 |
| Approved symbol | ZNF550 |
| Name | zinc finger protein 550 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC41917 |
| Ensembl gene | ENSG00000251369 |
| Ensembl biotype | protein_coding |
| Entrez | 162972 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 nonsense_mediated_decay, 3 protein_coding, 1 retained_intron
ENST00000344222, ENST00000376230, ENST00000447310, ENST00000457177, ENST00000506609, ENST00000595560, ENST00000601415, ENST00000699333
RefSeq mRNA: 5 — MANE Select: NM_001397372
NM_001277090, NM_001277091, NM_001277092, NM_001277093, NM_001397372
CCDS: CCDS35500
Canonical transcript exons
ENST00000699333 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001678372 | 57559656 | 57559863 |
| ENSE00003064890 | 57556231 | 57556357 |
| ENSE00003113217 | 57552627 | 57552722 |
| ENSE00003976281 | 57541838 | 57547993 |
Expression profiles
Bgee: expression breadth ubiquitous, 245 present calls, max score 94.25.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.7631 / max 96.2539, expressed in 1509 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182909 | 2.8754 | 1261 |
| 182908 | 1.8877 | 973 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 94.25 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 85.17 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.61 | gold quality |
| tibia | UBERON:0000979 | 82.08 | gold quality |
| cortical plate | UBERON:0005343 | 81.48 | gold quality |
| ventricular zone | UBERON:0003053 | 81.00 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 80.83 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 80.28 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.16 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.57 | gold quality |
| ovary | UBERON:0000992 | 78.92 | gold quality |
| lymph node | UBERON:0000029 | 78.87 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.42 | gold quality |
| granulocyte | CL:0000094 | 78.17 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.17 | gold quality |
| left ovary | UBERON:0002119 | 77.95 | gold quality |
| apex of heart | UBERON:0002098 | 77.12 | gold quality |
| spleen | UBERON:0002106 | 76.97 | gold quality |
| right ovary | UBERON:0002118 | 76.94 | gold quality |
| heart left ventricle | UBERON:0002084 | 76.77 | gold quality |
| cardiac ventricle | UBERON:0002082 | 76.58 | gold quality |
| tonsil | UBERON:0002372 | 76.31 | gold quality |
| upper leg skin | UBERON:0004262 | 76.28 | gold quality |
| colonic epithelium | UBERON:0000397 | 76.25 | gold quality |
| adrenal tissue | UBERON:0018303 | 76.12 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.10 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.07 | gold quality |
| skin of leg | UBERON:0001511 | 76.03 | gold quality |
| pituitary gland | UBERON:0000007 | 76.00 | gold quality |
| endometrium | UBERON:0001295 | 76.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.75 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)
Protein
Protein identifiers
Zinc finger protein 550 — Q7Z398 (reviewed: Q7Z398)
All UniProt accessions (4): A0A0C4DGB4, Q7Z398, M0QWZ8, M0R337
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z398-1 | 1 | yes |
| Q7Z398-2 | 2 |
RefSeq proteins (5): NP_001264019, NP_001264020, NP_001264021, NP_001264022, NP_001384301* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050329 | GLI_C2H2-zinc-finger | Family |
Pfam: PF00096, PF01352
UniProt features (15 total): zinc finger region 8, chain 1, domain 1, region of interest 1, compositionally biased region 1, splice variant 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z398-F1 | 67.30 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 59 (showing top):
BIDUS_METASTASIS_UP, MASSARWEH_TAMOXIFEN_RESISTANCE_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, PRC2_SUZ12_UP.V1_UP, IL21_UP.V1_DN, OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP, JAK2_DN.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, ZNF8_TARGET_GENES, ZNF92_TARGET_GENES, MIR95_5P
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892), positive regulation of transcription by RNA polymerase II (GO:0045944), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), transcription cis-regulatory region binding (GO:0000976), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 2 |
| DNA-templated transcription | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| negative regulation of RNA biosynthetic process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| transcription regulatory region nucleic acid binding | 1 |
| sequence-specific double-stranded DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
628 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF550 | OR2A2 | Q6IF42 | 590 |
| ZNF550 | FREY1 | C9JXX5 | 541 |
| ZNF550 | U2SURP | O15042 | 437 |
| ZNF550 | PPP1R14D | Q9NXH3 | 428 |
| ZNF550 | UBTD1 | Q9HAC8 | 400 |
| ZNF550 | ERVMER34-1 | Q9H9K5 | 394 |
| ZNF550 | SYPL1 | Q16563 | 359 |
| ZNF550 | UTP15 | Q8TED0 | 357 |
| ZNF550 | NAPG | Q99747 | 333 |
| ZNF550 | GPAA1 | O43292 | 324 |
| ZNF550 | PPP2R3C | Q969Q6 | 311 |
| ZNF550 | NCKIPSD | Q9NZQ3 | 308 |
| ZNF550 | RABGAP1L | Q5R372 | 302 |
| ZNF550 | CREBRF | Q8IUR6 | 299 |
| ZNF550 | DNAH3 | Q8TD57 | 290 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF550 | REL | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF550 | MDM2 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF550 | MEIOC | psi-mi:“MI:0914”(association) | 0.350 |
| NOL4 | ZNF195 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF550 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC27A4 | IPO5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (97): ZNF550 (Two-hybrid), C17orf104 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), YTHDC2 (Affinity Capture-MS), TRIM37 (Affinity Capture-MS), ZNF460 (Affinity Capture-MS), ZNF92 (Affinity Capture-MS), RBAK (Affinity Capture-MS), USP34 (Affinity Capture-MS), TRIM41 (Affinity Capture-MS), FBLN5 (Affinity Capture-MS), PPP2CA (Affinity Capture-MS), STRN4 (Affinity Capture-MS), PPP2R1B (Affinity Capture-MS), STRN3 (Affinity Capture-MS)
ESM2 similar proteins: A2A761, A2T7D2, A3KN32, A3KN36, A7MBI1, B2RXC5, E9PYI1, O43296, P0CG31, P10072, P10078, P17023, P17097, P18725, P18728, P52738, Q02525, Q07231, Q0VCB0, Q12901, Q14592, Q49AA0, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RB33, Q5RBX0, Q5RBY9, Q61967, Q62396, Q6PF04, Q6ZNG0, Q6ZS27, Q7Z398, Q80YP6, Q8BIQ3, Q8IZ26, Q96N20
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1032 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57556225:CATTA:C | donor_loss | 1.0000 |
| 19:57556226:ATTAC:A | donor_loss | 1.0000 |
| 19:57556228:TACC:T | donor_loss | 1.0000 |
| 19:57556229:A:C | donor_loss | 1.0000 |
| 19:57556353:AACAT:A | acceptor_gain | 1.0000 |
| 19:57556354:ACAT:A | acceptor_gain | 1.0000 |
| 19:57556355:CAT:C | acceptor_gain | 1.0000 |
| 19:57556355:CATC:C | acceptor_gain | 1.0000 |
| 19:57556356:AT:A | acceptor_gain | 1.0000 |
| 19:57556356:ATCTG:A | acceptor_loss | 1.0000 |
| 19:57556358:C:CC | acceptor_gain | 1.0000 |
| 19:57556358:CT:C | acceptor_loss | 1.0000 |
| 19:57559651:CTCA:C | donor_loss | 1.0000 |
| 19:57559652:TCA:T | donor_loss | 1.0000 |
| 19:57559653:CA:C | donor_loss | 1.0000 |
| 19:57559655:C:CT | donor_loss | 1.0000 |
| 19:57544457:AGGG:A | donor_gain | 0.9900 |
| 19:57544503:T:TA | donor_gain | 0.9900 |
| 19:57552621:GCTTA:G | donor_loss | 0.9900 |
| 19:57552622:CTTA:C | donor_loss | 0.9900 |
| 19:57552624:TACCT:T | donor_loss | 0.9900 |
| 19:57552625:A:AT | donor_loss | 0.9900 |
| 19:57552719:TGCC:T | acceptor_gain | 0.9900 |
| 19:57556359:T:A | acceptor_loss | 0.9900 |
| 19:57556367:C:CT | acceptor_gain | 0.9900 |
| 19:57559650:GCTCA:G | donor_loss | 0.9900 |
| 19:57559654:A:AC | donor_gain | 0.9900 |
| 19:57559655:C:CC | donor_gain | 0.9900 |
| 19:57552719:TGCCC:T | acceptor_loss | 0.9800 |
| 19:57552720:GCCCT:G | acceptor_loss | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000003470 (19:57553769 G>A), RS1000183925 (19:57545838 C>G,T), RS1000231384 (19:57545537 G>GAC), RS1000239305 (19:57553555 T>A,C), RS1000344498 (19:57551556 T>C), RS1000473403 (19:57558441 A>G), RS1000555832 (19:57547319 G>A,C), RS1000626422 (19:57559826 C>A,T), RS1000630023 (19:57553719 A>T), RS1000696817 (19:57552107 G>A,T), RS1000806527 (19:57559823 GC>G), RS1000880706 (19:57542303 T>C), RS1000957664 (19:57555237 A>G), RS1001157429 (19:57548348 G>T), RS1001232206 (19:57548577 C>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| terbufos | increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| pentabromodiphenyl ether | increases expression | 1 |
| abrine | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Fonofos | increases methylation | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Parathion | increases methylation | 1 |
| Phenobarbital | affects expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Zinc | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Gold Compounds | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.